Table 4.
Comparison of basic clinical information and laboratory results of patients in Group B [xˉ ± s, M(Q1, Q3)].
| Projects | Antagonist regimen (B1) | PPOS Program (B2) | Z/t/x² values | P value |
|---|---|---|---|---|
| Number of cycles | 191 | 339 | ||
| Age of woman (years) | 31.5 (29, 33) | 31 (29, 33) | 0.266 | 0.790 |
| Body mass index (kg/m2) | 23.68 ± 0.26 | 23.53 ± 0.19 | 0.481 | 0.631 |
| Years of infertility (years) | 3(2,5) | 3(2,5) | -0.491 | 0.623 |
| Anti-Mullerian hormone (ng/ml) | 0.85(0.71,1.00) | 0.82(0.68,0.99) | -1.167 | 0.243 |
| Basal FSH (IU/L) | 8.32 (6.04, 9.58) | 8.37 (6.60, 10.71) | -1.774 | 0.201 |
| Basal E2 (pmol/L) | 159.05 (119.96, 192.84) | 146.4 (104.35,196.4) | -1.639 | 0.101 |
| Sinus follicle count AFC | 8(6,11) | 7(5,10) | -4.119 | <0.001 |
| Gn initiation volume (U) | 300 (225, 300) | 300 (300, 300) | -6.558 | <0.001 |
| Gn Duration of use (d) | 10 (8, 11) | 9 (8, 11) | -0.914 | 0.361 |
| hCG Day | ||||
| hCG day endometrial thickness (mm) | 10.36 ± 0.17 | 7.93 ± 0.11 | 12.329 | <0.001 |
| hCG day LH (IU/L) | 1.8 (1.1125, 2.975) | 3.035 (1.81, 4.608) | -6.516 | <0.001 |
| hCG day estradiol (pmol/L) | 3362 (1582, 6232.5) | 5065 (3319.5,7478.5) | -5.373 | <0.001 |
| Total number of eggs harvested (pieces) | 6 (4, 9) | 5 (3, 7) | -3.284 | 0.001 |
| 2PN number (pieces) | 3 (2, 5) | 3 (2, 5) | -1.772 | 0.085 |
| Number of embryos available (pieces) | 3 (2, 4) | 2 (1, 4) | -2.094 | 0.036 |
| Number of good-quality embryos (pieces) | 1 (0, 2) | 1 (0, 3) | -0.413 | 0.680 |
| Cumulative live birth rate | 49.7% (95/191) | 35.7% (121/339) | 9.981 | 0.002 |
| Optimistic cumulative live birth rate | 49.3% (110/223) | 35.6% (154/432) | 11.439 | <0.001 |
| Conservative cumulative live birth rate | 42.6% (95/223) | 28.0% (121/432) | 14.168 | <0.001 |